Cannabis Investors: We Finally Have a Pot Stock That’s Attractively Valued!

CannTrust Holdings Inc. (TSX:TRST)(NYSE:CTST) could easily triple in price. Here’s how.

edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

If you’re a value investor like I am, you wouldn’t think about touching cannabis stocks with a barge pole. The valuations slapped on most cannabis names have been and continue to be absurd beyond proportion. And while you’ve probably shunned the industry by now, it may come as a surprise that we finally have a pot stock with a valuation that’s aligned with reality.

Enter CannTrust Holdings (TSX:TRST)(NYSE:CTST), a pot stock that’s been under a significant amount of pressure over the last few months over news that can’t seem to get any worse. It’s too bad that it had to be this way, but the stock is attractively valued, even with the baggage and the scandal that’s unfolded before us.

What happened?

In case you’ve been tuned out, CannTrust is in hot water over cannabis growth in unlicensed rooms. Shares slid 22% in a single trading session when it was reported that CEO Peter Aceto told senior staff to “continue as planned.”

Health Canada is going to unleash its fury with some sort of punishment. And right now, further investigations are needed to see if management had bad intentions from the beginning or if they were unintentionally caught offside. I think it’s the latter, and if this is found to be the case, CannTrust may get a penalty that’s closer to a slap on the wrist than one that’ll result in its ultimate demise.

From a risk/reward standpoint, I like the name much more than its nonsensically valued peers which aren’t at risk of being put in the penalty box. CannTrust trades at around 6.4 times sales, which is a bargain when it comes to the cannabis industry and the quality of underlying assets you’re getting.

Moreover, cannabis stocks are all about exaggerated moves; whether it’s to the upside or downside, you can be sure that the market value of a pot stock will be a far cry away from its intrinsic value. After suffering a +80% peak-to-trough drop, CannTrust is looking ripe for picking for us patient value investors.

While there’s still a tonne of risk, I believe that it won’t take much to move the needle higher at CannTrust. Whether it’s through the ousting of executives, the discovery of a misunderstanding that’s been exaggerated and interpreted the wrong way by media outlets, or milder-than-expected penalties faced, I think CannTrust is capable of posting triple-digit percentage upward movements over the coming weeks.

I’d argue that CannTrust at a reasonable multiple is a better bet than any other pot stock like Canopy Growth, which trades at over 50 times sales. So, if you’ve got disposable income, now is the time to have a close look at CannTrust before the stock has a chance to pay its dues and step out of the penalty box.

Stay hungry. Stay Foolish.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »